Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase II data reported for GV-1001 in moderate to severe Alzheimer's disease

April 6, 2021

Phase III trial investigates TQB-2450 with anlotinib for advanced biliary cancer

April 6, 2021

Tsukushi protein mutations can lead to hydrocephalus

April 1, 2021

FDA approves Roszet to treat elevated LDL-C in primary nonfamilial hyperlipidemia and HoFH

April 1, 2021

Celon reports phase I data on second-generation GPR40 agonist CPL-280

April 1, 2021

U.S. approval for Sarclisa with Kd for relapsed or refractory multiple myeloma

April 1, 2021

Yingli reports phase II topline data on linperlisib in relapsed or refractory follicular lymphoma

April 1, 2021

China's NMPA approves Ayvakit for GIST with PDGFRA exon 18 mutation

April 1, 2021

Qinlock approved in China for advanced GIST

April 1, 2021

Primary safety endpoint met in phase Ib/II study of BXCL-501 to treat opioid withdrawal symptoms

April 1, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...